Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks

Vaccine

Volumn 28, Issue 46, 2010, Pages 7381-7388

  Valenciano, Marta ^a   Kissling, Esther ^a   Ciancio, Bruno Christian ^b   Moren, Alain ^a  

^a EPICONCEPT   (France)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Effectiveness; Influenza vaccine; Sentinel practitioner networks

Indexed keywords

INFLUENZA VACCINE;

ACCESS TO INFORMATION; ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; EUROPE; FEASIBILITY STUDY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LABORATORY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCREENING;

CONFOUNDING FACTORS (EPIDEMIOLOGY); EUROPE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RESEARCH DESIGN; SENTINEL SURVEILLANCE;

EID: 77958179002     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.010     Document Type: Article

References (57)

1. Fiore A.E., Shay D.K., Broder K., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009 Jul, 58(RR-8):1-52.
2. European Centre for Disease Prevention and Control (ECDC). European Influenza Surveillance Network (EISN). [2010]. 2010. Stockolm, ECDC. Available: Accessed 20 June 2010. http://www.ecdc.europa.eu/en/activities/surveillance/EISN.
3. Valenciano M., Ciancio B., Moren A. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveill 2008 Oct, 13.(43).
4. ECDC. Protocol for case control studies to measure pandemic and seasonal vaccine effectiveness in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2010. Availble: Accessed 20 June 2010. http://www.ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf.
5. ECDC. Protocol for cohort database studies to measure pandemic and seasonal vaccine effectiveness in the European Union and European Economic Area. Stockholm: European Centre for Disease Prevention and Control; 2010. Available: Accessed 20 June 2010. http://www.ecdc.europa.eu/en/publications/Publications/0907_TER_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Cohort_Database_Studies.pdf.
6. Kissling E., Valenciano M., Falcao J., et al. " I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill 2009, 14(44).
7. Pitigoi D., Lupulescu E., Alexandrescu V., et al. Efficiency of seasonal influenza vaccine in persons older than 65 in Romania.Pilot case-control study I-MOVE, 2008-2009. Bacteriol Virusol Parazitol Epidemiol 2009 Apr, 54(2):109-116.
8. Savulescu C., Valenciano M., de M.S., Larrauri A. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups 2008-2009 season, Spain. Vaccine 2010 Feb.
9. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007 Sep, 25(39-40):6852-6862.
10. Nichol K.L. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine 2009 Oct, 27(45):6305-6311.
11. Nichol K.L. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine 2006 Nov, 24(44-46):6726-6728.
12. Orenstein W.A., Bernier R.H., Dondero T.J., et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985, 63(6):1055-1068.
13. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals.A randomized double-blind placebo-controlled trial. JAMA 1994 Dec, 272(21):1661-1665.
14. Nichol K.L., Mendelman P. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses. Virus Res 2004 Jul, 103(1-2):3-8.
15. Foster D.A., Talsma A., Furumoto-Dawson A., et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992 Aug, 136(3):296-307.
16. Puig-Barbera J., Diez-Domingo J., Varea A.B., et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007 Oct, 25(42):7313-7321.
17. Orenstein E.W., De Serres G., Haber M.J., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007 Jun, 36(3):623-631.
18. Klimov A.I., Rocha E., Hayden F.G., Shult P.A., Roumillat L.F., Cox N.J. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis 1. J Infect Dis 1995 Nov, 172(5):1352-1355.
19. Leekha S., Zitterkopf N.L., Espy M.J., Smith T.F., Thompson R.L., Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control 5. Infect Control Hosp Epidemiol 2007 Sep, 28(9):1071-1076.
20. Sato M., Hosoya M., Kato K., Suzuki H. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005 Oct, 24(10):931-932.
21. Weinstock D.M., Gubareva L.V., Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003 Feb, 348(9):867-868.
22. Lee N., Chan P.K., Hui D.S., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza 8. J Infect Dis 2009 Aug, 200(4):492-500.
23. De S.G., Rouleau I., Hamelin M.E., et al. Contagious period for pandemic (H1N1) 2009 1. Emerg Infect Dis 2010 May, 16(5):783-788.
24. Mangtani P., Cumberland P., Hodgson C.R., Roberts J.A., Cutts F.T., Hall A.J. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004 Jul, 190(1):1-10.
25. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007 Oct, 357(14):1373-1381.
26. Hak E., Verheij T.J., Grobbee D.E., Nichol K.L., Hoes A.W. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002 Dec, 56(12):951-955.
27. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006 Apr, 35(2):337-344.
28. Simonsen L., Viboud C., Taylor R.J., Miller M.A., Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009 Oct, 27(45):6300-6304.
29. Jackson L.A., Nelson J.C., Benson P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006 Apr, 35(2):345-352.
30. Belongia E.A., Kieke B.A., Donahue J.G., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009 Jan, 199(2):159-167.
31. Skowronski D.M., Masaro C., Kwindt T.L., et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007 Apr, 25(15):2842-2851.
32. Gruber W.C., Kirschner K., Tollefson S., et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J Infect Dis 1993 Jul, 168(1):53-60.
33. Ortqvist A., Granath F., Askling J., Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J 2007 Sep, 30(3):414-422.
34. Ozasa K., Kawahito Y., Doi T., et al. Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan. Vaccine 2006 Mar, 24(14):2537-2543.
35. Tacken M.A., Braspenning J.C., Berende A., et al. Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine 2004 Aug, 22(23-24):2985-2992.
36. Vila-Corcoles A., Rodriguez T., de Diego C., et al. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine 2007 Sep, 25(37-38):6699-6707.
37. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008 Aug, 372(9636):398-405.
38. Castilla J., Arregui L., Baleztena J., et al. Incidence of influenza and influenza vaccine effectiveness in the 2004-2005 season. An Sist Sanit Navar 2006 Jan, 29(1):97-106.
39. Fleming D.M., Watson J.M., Nicholas S., Smith G.E., Swan A.V. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect 1995 Dec, 115(3):581-589.
40. Voordouw B.C., Sturkenboom M.C., Dieleman J.P., Stijnen T., van der L.J., Stricker B.H. Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia. Arch Intern Med 2006 Oct, 166(18):1980-1985.
41. Hviid A. Effectiveness of two pertussis vaccines in preterm Danish children. Vaccine 2009 May, 27(23):3035-3038.
42. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007 Oct, 7(10):658-666.
43. Halloran M.E., Longini I.M. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol 2001 Sep, 154(5):391-398.
44. Scharfstein D.O., Halloran M.E., Chu H., Daniels M.J. On estimation of vaccine efficacy using validation samples with selection bias. Biostatistics 2006 Oct, 7(4):615-629.
45. Skowronski D.M., De S.G., Dickinson J., et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009 Jan, 199(2):168-179.
46. Kelly H., Carville K., Grant K., Jacoby P., Tran T., Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009, 4(3):e5079.
47. Fleming D.M., Andrews N.J., Elllis J.S., et al. Estimating Influenza vaccine effectiveness using routinely collected laboratory data 2. J Epidemiol Community Health 2009 Nov.
48. Uphoff H., Hauri A.M., Schweiger B., et al. Estimation of influenza vaccine effectiveness using routine surveillance data 5. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006 Mar, 49(3):287-295.
49. Rodrigues L., Kirkwood B.R. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 2010, 19(1):205-213.
50. Mazick A., Christiansen A.H., Samuelsson S., Molbak K. Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: a pilot study in Denmark. Euro Surveill 2006, 11(10):254-256.
51. Mereckiene J., Cotter S., Weber J.T., et al. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill 2008 Oct, 13(41).
52. Carrat F., Tachet A., Rouzioux C., Housset B., Valleron A.J. Field investigation of influenza vaccine effectiveness on morbidity. Vaccine 1998 May, 16(9-10):893-898.
53. Farrington C.P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993 Aug, 22(4):742-746.
54. Legrand J., Vergu E., Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006 Nov, 24(44-46):6605-6611.
55. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States May-June 2009. MMWR Morb Mortal Wkly Rep 2009 Nov, 58(44):1241-1245.
56. Wichmann O., Stocker P., Poggensee G., et al. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill 2010, 15(18).
57. ECDC. Protocol for cluster investigations to measure pandemic and seasonal vaccine effectiveness in the EU and EEA. European Centre for Disease Prevention and Control; 2010. Available: Accessed 20 June 2010. http://www.ecdc.europa.eu/en/publications/Publications/0912_TED_Protocol_for_Cluster_Investigations_to_Measure_Influenza_Vaccine_Effectiveness.pdf.